J. Moore

University of California, Los Angeles — United States

Medicine · Health Sciences

17h-index3.3kcitations51works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Esophageal Cancer Research and Treatment(16), Gastric Cancer Management and Outcomes(14), Immunotherapy and Immune Responses(8), Lung Cancer Treatments and Mutations(5), Cancer Immunotherapy and Biomarkers(4)

Publications51 total

Five-year follow-up of prostate specific membrane antigen PET/CT-guided salvage radiotherapy following radical prostatectomy: A single center retrospective analysis.
Journal of Clinical Oncology·2025
Reply to R. Sun et al
Journal of Clinical Oncology·2023
OGC P01 Evaluating the use of FDG PET-CT for restaging patients with oesophageal adenocarcinoma treated with neoadjuvant chemotherapy
British journal of surgery·2023Open Access
OGC P37 Long term follow-up of patients undergoing prehabilitation prior to oesophagectomy: What happens to patients declining or withdrawing from prehabilitation exercise programmes?
British journal of surgery·2023Open Access
PSMA PET Guided Salvage Radiotherapy Among Prostate Cancer Patients in the Post-Prostatectomy Setting: A Single Center Post-Hoc Analysis
International Journal of Radiation Oncology*Biology*Physics·2023Open Access
Prehabilitation exercise before oesophagectomy: long-term follow-up of patients declining/withdrawing from the program
British journal of surgery·2023· 8 cited
Pathologic Lymph Node Regression After Neoadjuvant Chemotherapy Predicts Recurrence and Survival in Esophageal Adenocarcinoma: A Multicenter Study in the United Kingdom
Journal of Clinical Oncology·2023· 32 cited
Delayed Surgical Intervention After Chemoradiotherapy in Esophageal Cancer
Annals of Surgery·2023· 19 citedOpen Access
PSMA PET guided salvage radiotherapy among patients with prostate cancer in the post-prostatectomy setting: A single center post-hoc analysis.
Journal of Clinical Oncology·2023
Metabolic tumour and nodal response to neoadjuvant chemotherapy on FDG PET-CT as a predictor of pathological response and survival in patients with oesophageal adenocarcinoma
European Radiology·2023· 9 citedOpen Access
A O04 Identifying Predictive Factors for Prolonged use of Nutritional Support After Oesophagogastric Cancer Resections
British journal of surgery·2022Open Access
OGC P20 Metabolic tumour and nodal response to neoadjuvant chemotherapy on FDG PET-CT as a predictor of pathological response and survival in patients undergoing surgical resection for locally advanced oesophageal adenocarcinoma
British journal of surgery·2022
OGC O02 The prognostic effect of pathological lymph node regression after neoadjuvant chemotherapy for oesophageal adenocarcinoma – a multicentre study
British journal of surgery·2022Open Access
OGC P27 A Review of Minimally Invasive Oesophagogastric Cancer Surgery in a High-Volume UK Unit
British journal of surgery·2022
577. FDG PT-CT METABOLIC TUMOUR AND NODAL RESPONSE AS A PREDICTOR OF PATHOLOGICAL RESPONSE AND SURVIVAL IN PATIENTS WITH OESOPHAGEAL ADENOCARCINOMA
Diseases of the Esophagus·2022
568. THE PROGNOSTIC EFFECT OF PATHOLOGICAL LYMPH NODE REGRESSION AFTER NEOADJUVANT CHEMOTHERAPY FOR OESOPHAGEAL ADENOCARCINOMA – A MULTICENTRE STUDY
Diseases of the Esophagus·2022Open Access
187: EFFECT OF PERI-OPERATIVE CHEMOTHERAPY REGIMEN ON SURVIVAL IN THE TREATMENT OF LOCALLY ADVANCED GASTRO-OESOPHAGEAL ADENOCARCINOMA—FLOT VS ‘MAGIC’
Diseases of the Esophagus·2022
Patient perspectives on key symptoms and preferences for follow-up after upper gastro-intestinal cancer surgery
Supportive Care in Cancer·2022· 2 citedOpen Access
Effect of peri-operative chemotherapy regimen on survival in the treatment of locally advanced oesophago-gastric adenocarcinoma – A comparison of the FLOT and ‘MAGIC’ regimens
European Journal of Cancer·2022· 16 cited
ASO Visual Abstract: Clinical Relevance of the Tumor Location-Modified Laurén Classification System of Gastric Cancer in a Western Population
Annals of Surgical Oncology·2022Open Access
page 1 of 3Next →

Frequent Co-authors

James Gossage(16), Cara Baker(15), Jesper Lagergren(13), Andrew Davies(13), Mieke Van Hemelrijck(12), Nick Maisey(11), Mark Kelly(10), Martin Gore(9), Aida Santaolalla(9), Harriet Deere(8), Jason Dunn(7), Sebastian Zeki(7), Vicky Goh(6), Mark Hill(6), G. Tham(6), A. Lorentzos(6), H. Atkinson(5), Roger A’Hern(5), P. Riches(5), Michael Green(5)